Prosecution Insights
Last updated: October 04, 2026

Winfield Solutions LLC

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials

4 pending office actions • 2 art units • 3 examiners • 0 of 4 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days

Analysis

Winfield Solutions LLC manages a patent portfolio in the Biotechnology & Pharmaceuticals technology area with 3 pending office actions. These actions are distributed among 3 distinct examiners. The prosecution activity takes place across 2 distinct art units, indicating that the company's biotechnology filings are being reviewed by more than one specialized technical group. The involvement of 2 distinct art units within the Biotechnology & Pharmaceuticals field suggests that the company's innovations cover different technical niches.

CABRAL, ROBERT S is the busiest examiner for the company, currently managing 1 pending office action. Because there are 3 pending actions and 3 distinct examiners, each examiner is responsible for exactly 1 action. This shows an even distribution of the workload among CABRAL, ROBERT S and two other officials. The 3 to 3 ratio of actions to examiners means that each pending application is receiving a unique review from a different individual at the patent office. This distribution provides a variety of examiner perspectives on the company's intellectual property.

Practitioners must navigate the specific standards of 2 different units while dealing with 3 different examiners. This profile represents a balanced prosecution environment where individual examiner attention is maintained across multiple technical departments. The involvement of 2 distinct art units suggests that the company's innovations touch upon different sub-specialties within the Biotechnology & Pharmaceuticals sector. This data provides a baseline for future filings, as any expansion in the portfolio will likely introduce new examiners or art units.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

4
Total Pending OAs
2
Non-Final OAs
1
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (25%)
3
Medium (75%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only2 (50%)
Double-patenting + other1 (25%)
Multi-statute (no §101)1 (25%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
50% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
2
Business / Other
50% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

40 h
Manual time on pending OAs
8 h
Time saved (low, 20%)
14 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
CABRAL, ROBERT S 2 62.6% +32.5%
FAY, ZOHREH ALEMZADEH 1 52.2% -6.2%
GERIDO, DWAN A 1 58.0% +30.4%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18886715 DRIFT REDUCTION ADJUVANT COMPOSITIONS AND METHODS OF USING SAME CABRAL, ROBERT S —

Interview Candidates (3)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18348543 SOIL-BASED DNA EXTRACTION GERIDO, DWAN A 9d
18886715 DRIFT REDUCTION ADJUVANT COMPOSITIONS AND METHODS OF USING SAME CABRAL, ROBERT S —
18829439 DRIFT REDUCTION ADJUVANT COMPOSITIONS AND METHODS OF USING SAME CABRAL, ROBERT S —

Top Art Units

Art UnitApps
1617 1
1797 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18886715 DRIFT REDUCTION ADJUVANT COMPOSITIONS AND METHODS OF USING SAME CABRAL, ROBERT S — §102§103§112Other Non-Final OA — Pending Sep 16, 2024
18829439 DRIFT REDUCTION ADJUVANT COMPOSITIONS AND METHODS OF USING SAME CABRAL, ROBERT S — §103§112DP Non-Final OA — Pending Sep 10, 2024
18543825 MULTIFUNCTIONAL AGRICULTURAL ADJUVANT COMPOSITIONS FAY, ZOHREH ALEMZADEH 1617 §103 Non-Final OA 4d overdue Pending Dec 18, 2023
18348543 SOIL-BASED DNA EXTRACTION GERIDO, DWAN A 1797 §103 Final Rejection 9d Pending Jul 07, 2023

Managing Winfield Solutions LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month